Attached files

file filename
EX-23.1 - EXHIBIT 23.1 - CONSENT - Nemaura Medical Inc.ex23x1.htm
EX-32.1 - EXHIBIT 32.1 - Nemaura Medical Inc.ex32x1.htm
EX-31.2 - EXHIBIT 31.2 - Nemaura Medical Inc.ex31x2.htm
EX-31.1 - EXHIBIT 31.1 - Nemaura Medical Inc.ex31x1.htm
EX-21.1 - EXHIBIT 21.1 - Nemaura Medical Inc.ex21x1.htm
EX-3.3 - EXHIBIT 3.3 - AMENDED AND RESTATED BYLAWS - Nemaura Medical Inc.ex3x3.htm
EX-3.2 - EXHIBIT 3.2 - CERTIFICATE OF DESIGNATION FOR SERIES A CONVERTIBLE PREFERRED STOC - Nemaura Medical Inc.ex3x2.htm
EX-3.1(A) - EXHIBIT 3.1(A) - CERTIFICATE OF AMENDMENT TO THE ARTICLES OF INCORPORATION - Nemaura Medical Inc.ex3x1a.htm
10-K - FORM 10-K - Nemaura Medical Inc.nmra_10k-033118.htm

EXHIBIT 32.2
WRITTEN STATEMENT
PURSUANT TO
18 U.S.C. SECTION 1350

In connection with Annual Report of Nemaura Medical Inc. and its subsidiaries (the “ Company ”) on Form 10-K for the year ended March 31, 2018 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, Iain S Anderson, Chief Financial Officer (Principal Financial Officer) of the Company, certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
 
(1)  The Report fully complies with the requirements of Section 13a-14(b) or 15d-14(b) of the Securities Exchange Act of 1934; and
 
(2)  The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: June 12, 2018
By:
/s/ Iain S Anderson 
 
Name:
Iain S Anderson
 
Title:
Chief Financial Officer (Principal Financial Officer)